UnknownNot Applicable

Supervised Group-based Walking Intervention Among Inactive Older Adults in Saudi Arabia

126 participantsStarted 2022-01-01

Plain-language summary

The purpose of the proposed study is to compare the effects of supervised group-based walking and non-supervised individual-based walking interventions on frailty, cognitive function and quality of life among inactive older adults in Saudi Arabia.

Who can participate

Age range

60 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 60-70 years old * capable of walking without assistive device * healthy and live independently in communities * being physically inactive Exclusion Criteria: * with cardiovascular or related diseases that prevent from intensive walking * fail the PAR-Q screening or without physician's advice on readiness of participation in exercise training * diagnosed with cognitive impairment

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change from baseline Health-related quality of life at 4 months and at 7 months

Timeframe: Time 1: Baseline; TIme 2 after the 16-week intervention; Time 3 12-weeks after the intervention

Change from baseline Frailty level at 4 months and at 7 months

Timeframe: Time 1: Baseline; TIme 2 after the 16-week intervention; Time 3 12-weeks after the intervention

Change from baseline Cognitive function at 4 months and at 7 months

Timeframe: Time 1: Baseline; TIme 2 after the 16-week intervention; Time 3 12-weeks after the intervention

Trial details

NCT IDNCT05151575

SponsorHong Kong Baptist University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08-31

Contact for this trial

Chung Pak Kwong, Prof

34117728 pkchung@hkbu.edu.hk

View on ClinicalTrials.gov More Physical Activity trials

Who can participate

Age range

60 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change from baseline Health-related quality of life at 4 months and at 7 months

Timeframe: Time 1: Baseline; TIme 2 after the 16-week intervention; Time 3 12-weeks after the intervention

Change from baseline Frailty level at 4 months and at 7 months

Timeframe: Time 1: Baseline; TIme 2 after the 16-week intervention; Time 3 12-weeks after the intervention

Change from baseline Cognitive function at 4 months and at 7 months

Timeframe: Time 1: Baseline; TIme 2 after the 16-week intervention; Time 3 12-weeks after the intervention